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Abstract
Background: Pseudocarcinomatous hyperplasia of the fallopian tube is a rare, benign disease characterized by
florid epithelial hyperplasia.
Case presentation: The authors present the history and details of a 22-year-old woman with bilateral pelvic
masses and a highly elevated serum CA-125 level (1,056 U/ml). Ultrasonography and magnetic resonance imaging
(MRI) of the pelvis showed bilateral adnexal complex cystic masses with a fusiform or sausage-like shape.
Contrast-enhanced fat-suppressed T1-weighted images showed enhancement of papillary projections of the right
adnexal mass and enhancement of an irregular thick wall on the left adnexal mass, suggestive of tubal cancer.
Based on MRI and laboratory findings, laparotomy was performed under a putative preoperative diagnosis of tubal
cancer. The final pathologic diagnosis was pseudocarcinomatous hyperplasia of tubal epithelium associated with
acute and chronic salpingitis in both tubes.
Conclusion: The authors report a rare case of pseudocarcinomatous hyperplasia of the fallopian tubes mimicking
tubal cancer.
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Background
Various benign conditions of the female genital tract
may be confused with malignant neoplasms. Pseudocar-
cinomatous hyperplasia of fallopian tubes is a rare,
reactive response to an underlying inflammatory or
neoplastic process, and can mimic adenocarcinoma
clinically and pathologically. Epithelial hyperplasia of a
tube has been reported in association with estrogen
administration, estrogenic ovarian lesions, tuberculous
salpingitis, and nontuberculous salpingitis [1]. Mild to
moderate epithelial stratification, nuclear atypia, and
mitotic activity related to estrogenic stimulation might
be observed in the tubal epithelium, but florid or atyp-
ical hyperplasia sufficient to be confused with adenocar-
cinoma is rarely seen.
Since this condition has not been discussed extensively
in the literature, its differentiation from tubal cancer can
be problematic [2], and morphologic similarities between
pseudocarcinomatous hyperplasia and tubal cancer may
be sufficient to cause significant misdiagnosis [3]. Differ-
ential features that aid the discrimination of benign
pseudocarcinomatous hyperplasia of the fallopian tube
and tubal cancer should be considered to ensure accur-
ate diagnosis and proper management.
Herein, we present a case of pseudocarcinomatous
hyperplasia of fallopian tubes with chronic salpingitis
and endometriosis in tubes mimicking tubal cancer.
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Case presentation
A 22-year-old nulliparous woman presented with per-
sistent lower abdominal pain and vaginal spotting of
4 weeks’ duration. She was referred to our hospital due
to bilateral adnexal masses and a highly elevated CA-125
level (1,056 U/ml). Pelvic ultrasonography showed well
defined bilateral adnexal cysts with irregular thickened
walls (Fig. 1). Magnetic resonance imaging (MRI) was
performed to evaluate the pelvic mass further. Axial T2-
weighted images showed bilateral adnexal complex cystic
masses with fusiform or sausage-like shapes. The right
adnexal mass appeared as a cystic mass with papillary
projections and the left adnexal mass had an irregular
thick wall. The right ovary was normal, but the left ovary
was not visualized by MRI. Contrast-enhanced fat-
suppressed T1-weighted images showed enhancement of
papillary projections of the right adnexal mass and of
the irregular thick wall of the left adnexal mass (Fig. 2).
Then, laparotomy was performed under a putative pre-
operative diagnosis of tubal cancer. Initially both ovaries
were not visualized due to extensive firm, thick pelvic
adhesions (Fig. 3a). Both tubes were enlarged with thick-
ened walls. Intraoperative frozen section from right
salpinx revealed acute and chronic inflammation but no
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Fig. 2 a-d Axial T2-weighted images showing bilateral adnexal complex cystic masses with fusiform or sausage-like shapes. The right adnexal
mass (*) appeared as a cystic mass with papillary projections (arrowhead), whereas the left adnexal mass (long arrow) had an irregular thick wall.
The right ovary (short arrow) was normal, but the normal left ovary was not visualized by MRI. (e-f) Contrast-enhanced fat-suppressed T1-weighted
imaging revealed papillary projection enhancement (arrowhead) in the right adnexal mass and enhancement of the irregular thick wall (long arrow) in
the left adnexal mass. These MRI features were suggestive of fallopian tube cancer
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evidence of malignancy. Bilateral salpingectomy was
performed.
Grossly, both fallopian tubes were markedly dilated
with thickened tubal walls (Fig. 3b). Microscopic find-
ings revealed papillary growth and fusion of plicae
(Fig. 4a). The tubal epithelium showed nuclear crowding
and epithelial stratification with in a marked inflamma-
tory background; however, cytologic atypia was minimal
and mitoses were rare (Fig. 4b). Foci of endometriosis
was observed on the outer walls of fallopian tubes
(Fig. 4c), and CD10 immunostaining highlighted endo-
metrial stroma at these foci (Fig. 4d).
The final pathologic diagnosis was pseudocarcinoma-
tous hyperplasia of tubal epithelium associated with
acute and chronic salpingitis in both tubes and endomet-
riosis in the left tube.
Postoperative recovery was uneventful, and her CA-125
level normalized at 3 months after surgery. No recurrence
occurred over 18 months of postoperative follow-up.
Discussion
Pseudocarcinomatous hyperplasia is a pathologic diagno-
sis when a lesion exhibits florid epithelial hyperplasia
with atypical features. However, pseudocarcinomatous
hyperplasia of the fallopian tube is rare; a literature
review revealed that ~14 cases have been issued on
pseudocarcinomatous hyperplasia of the fallopian tube
in patients aged 17 to 40 years [1]. About 50 % of these
cases were associated with chronic salpingitis, whereas
the others were associated with pyosalpinx, tubo-ovarian
abscess, or hydrosalpinx (Table 1). Gupta et al. consid-
ered pseudocarcinomatous epithelial hyperplasia of
fallopian tubes was related to female genital tract tuber-
culosis and reported that it histologically mimicked
adenocarcinoma [2]. In our patient, it was associated
with acute and chronic salpingitis, and endometriosis.
Various benign conditions can be mistaken for malig-
nant neoplasms, both clinically and pathologically.
Microscopically, reactive atypical hyperplasia of fallopian
tubes can be confused with carcinoma due to following
microscopic findings: epithelial hyperplasia associated
with a cribriform pattern, penetration of tubal wall by
epithelium, or florid mesothelial hyperplasia. In initial
experience, a radical hysterectomy was performed due to
an erroneous diagnosis of carcinoma [1].
Pseudocarcinomatous hyperplasia is histologically dif-
ferentiated from adenocarcinoma. Several morphologic
features, such as, absence of a grossly detected tumor,
presence of marked chronic inflammation, lack of solid
epithelial proliferation, mild nuclear atypia, paucity of
mitotic figures, and no evidence of invasion of the tubal
wall, can help distinguish pseudocarcinomatous hyper-
plasia from tubal cancer, as in our case [1, 3] (Table 2).
The paucity of mitotic figures has been considered as an
important criterion to differentiate this lesion from
carcinoma [2]. In our case, mitotic figures were absent.
Pseudocarcinomatous hyperplasia can be differentiated
from malignancy based on the morphologic features
alone or combined use of morphologic features and
additional immunohistochenical staining. The role of
immunohistochemistry is quite variable between differ-
ent cancer types. Unfortunately, immunohistochemical
findings cannot aid the differentiation of pseudocarcino-




Fig. 3 a Operative finding. Both tubes were resected and ovaries were
grossly normal. The left ovary was partially resected and sutured due
to adhesion and a ruptured surface (b) Gross appearance of the
surgically resected tube. The tube was markedly dilated, thickened, and
inflamed. c Multiple sections were taken for histopathological
examination, but there was no gross evidence of tumor
Lee et al. Journal of Ovarian Research  (2016) 9:79 Page 3 of 5
et al. suggest that Stathmin 1 (STMN1) and p16 are
sensitive and specific adjunct biomarkers that, when
used with p53 and Ki-67, improve the diagnostic accur-
acy of tubal carcinoma when compared to morphologic-
ally normal tubal epithelium [4]. These biomarkers
might be helpful in difficult cases with diagnostic di-
lemma and the findings should be interpreted carefully.
Several characteristics and features facilitate the differ-
ential diagnosis of pseudocarcinomatous hyperplasia and
adenocarcinoma of the tube. First, patients with pseudo-
carcinomatous hyperplasia of tubes are younger. Second,
there is bilateral diffuse involvement of tubes with no
evidence of ovary involvement by any tumor. Third,
patients with pseudocarcinomatous hyperplasia exhibit
evidence of pelvic inflammatory disease (PID) either
grossly or microscopically, whereas carcinomas do not.
No previous report has described the imaging appear-
ance of pseudocarcinomatous hyperplasia of the fallopian
tube. In our patient, it was visualized by pelvic ultrasonog-
raphy and MRI as bilateral tubular cystic adnexal masses
with papillary projections of the right mass and an irregu-
lar thick wall on the left mass. Furthermore, both of these
features were intensely enhanced on contrast-enhanced
MR images. The detection of a dilated fallopian tube by




Fig. 4 a Dilated fallopian tubes revealed marked mucosal hyperplasia under low power magnification (H&E, ×10). b Magnification of boxed area
showing proliferating mucosa with nuclear crowding and epithelial stratification in a marked inflammatory background (H&E, ×200). c-d
Magnification of the circular area showing foci of endometriosis on the outer fallopian tube wall (H&E, ×200 and CD10, ×200)
Table 1 Pseudocarcinomatous hyperplasia of Fallopian tubes
Authors Age
(years)































Table 2 Clinico-pathological criteria for differentiation of
pseudocarcinomatous hyperplasia of tubes from adenocarcinoma
Pseudocarcinomatous hyperplasia Adenocarcinoma
1. Most patients are usually younger. 1. Most patients are
postmenopausal, with a
mean age of 62 years
2. It is always reactive and secondary.
Usually associated with underlying
chronic inflammation or
hyperestrogenic states
2. It is always primary.
3. It shows no gross evidence of tumor,
but there is inflamed, grossly dilated or
thickened tube.
3. Most carcinomas are
grossly evident.
4. Chronic inflammation is marked. 4. Chronic inflammation is
not prominent.
5. Solid epithelial proliferation is not
observed.
5. Solid epithelial proliferation
is variably evident.
6. Mild to moderate nuclear atypia is
observed
6. Nuclear atypia is prominent.
7. There are few mitotic figures. It has
been considered an important
criterion.
7. There are numerous mitotic
figures.
8. Invasion of the tubal wall is not
evident, but pseudoinvasion of the
muscularis by gland like structures or
lymphatic penetration by epithelial
cells can be observed.
8. True invasion of the tubal
wall is evident.
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origin, and is visualized as a thin-walled C- or S-shaped
tubular cystic structure. The fluid is anechoic or shows
low-level echoes by ultrasonography, and hyperintensity
on T2-weighted images and hypointensity or hyperinten-
sity (if hemorrhagic fluid is present) on T1-weighted
images [5, 6]. In our case, enhancing nodular lesions and
an irregular inner contour on MR images might have been
caused by proliferative mucosal hyperplasia within fallo-
pian tubes.
Radiologically, pseudocarcinomatous hyperplasia of
fallopian tube may mimic tubal cancer, chronic salpin-
gitis, or tubal tuberculosis. Tubal cancer also manifests
as a solid, cystic adnexal mass, and the presence of
enhancing intraluminal masses within a dilated tube is
suggestive of its presence. On the other hand, thick-
walled tubular adnexal cystic structures with intense
enhancement and surrounding inflammation are indica-
tive of salpingitis. However, thickened tube folding due
to inflammation can be mistaken for enhancing mural
nodules, and sometimes make it difficult to differentiate
chronic salpingitis and tubal carcinoma [5, 6].
Pseudocarcinomatous hyperplasia of the fallopian tube
is a rare disease and its radiologic features overlap with
other fallopian tube diseases, such as, tubal cancer and
salpingitis, and thus, intraoperative frozen section is
needed to confirm the diagnosis.
Serum CA125 levels may provide information
preoperatively that aid the differentiation of benign and
malignant adnexal masses [7], and levels are significantly
higher in patients with tube cancer than in patients with
benign pelvic masses [3]. However, preoperative CA125
lacks the specificity needed to predict effectively the
presence of malignancy [8].
Conclusion
In conclusion, pseudocarcinomatous hyperplasia of the
fallopian tube is a benign, reactive response to an under-
lying inflammatory process. Accurate discrimination is
dependent on the identification of morphologic features,
because there are no characteristic immunohistochemi-
cal findings that aid the differentiation of pseudocarcino-
matous hyperplasia and tubal carcinoma. Thus, a
meticulous morphological assessment is required to
avoid an erroneous diagnosis of tubal cancer and subse-
quent overtreatment of this benign disease.
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